What is Bristol-Myers Squibb's alliance and other revenues — total revenues?

Bristol-Myers Squibb (BMY) reported alliance and other revenues — total revenues of $321M in Q1 2026.

How has Bristol-Myers Squibb's alliance and other revenues — total revenues changed year-over-year?

Bristol-Myers Squibb's alliance and other revenues — total revenues increased by 1.9% year-over-year, from $315M to $321M.

What is the long-term trend for Bristol-Myers Squibb's alliance and other revenues — total revenues?

Over 4 years (2021 to 2025), Bristol-Myers Squibb's alliance and other revenues — total revenues has grown at a 2.0% compound annual growth rate (CAGR), from $1.33B to $1.44B.

What does alliance and other revenues — total revenues mean?

Revenue earned from collaborative partnerships, profit-sharing, and royalty agreements with other companies.

Products & Services · Total Revenues

Alliance and other revenues — Total Revenues

Bristol-Myers Squibb Alliance and other revenues — Total Revenues decreased by 17.9% to $321M in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 1.9%, from $315M to $321M. Over 4 years (FY 2021 to FY 2025), Alliance and other revenues — Total Revenues shows relatively stable performance with a 2.0% CAGR. This decline may warrant attention — for this metric, higher values are generally preferred.

Analysis

StatementSegment

CategoryGrowth

SignalHigher is better

VolatilityModerate

First reportedQ1 2020

Last reportedQ1 2026Apr 30, 2026

Rolls up toTotal Revenue

How to read this metric

An increase suggests successful commercialization of partnered assets or higher royalty income, while a decrease may indicate expiring patents or reduced performance of co-marketed products.

Detailed definition

This metric represents revenue generated from collaborative arrangements, profit-sharing agreements, and royalty streams...

Peer comparison

Peer pharmaceutical companies often report this as 'Collaboration Revenue' or 'Other Operating Income,' though the composition varies based on the specific nature of licensing and co-promotion agreements.

Metric ID: bmy_segment_alliance_and_other_revenues_total_revenues

Historical Data

20 periods

	Q2 '21	Q3 '21	Q4 '21	Q1 '22	Q2 '22	Q3 '22	Q4 '22	Q1 '23	Q2 '23	Q3 '23	Q4 '23	Q1 '24	Q2 '24	Q3 '24	Q4 '24	Q1 '25	Q2 '25	Q3 '25	Q4 '25	Q1 '26
Value	$332.5M	$332.5M	$332.5M	$340M	$402M	$405M	$341M	$289M	$309M	$321M	$309M	$306M	$276M	$409M	$531M	$315M	$360M	$372M	$391M	$321M
QoQ Change	—	+0.0%	+0.0%	+2.3%	+18.2%	+0.7%	-15.8%	-15.2%	+6.9%	+3.9%	-3.7%	-1.0%	-9.8%	+48.2%	+29.8%	-40.7%	+14.3%	+3.3%	+5.1%	-17.9%
YoY Change	—	—	—	—	+20.9%	+21.8%	+2.6%	-15.0%	-23.1%	-20.7%	-9.4%	+5.9%	-10.7%	+27.4%	+71.8%	+2.9%	+30.4%	-9.0%	-26.4%	+1.9%

Range$276M – $531M

CAGR-0.7%

Avg YoY Growth+4.5%

Median YoY Growth+2.2%

Similar Metrics at Other Companies

PfizerPFE View metric

Neurocrine BiosciencesNBIX View metric

ModernaMRNA View metric

BiogenBIIB View metric

Roivant SciencesROIV View metric

BiogenBIIB View metric

Frequently Asked Questions

What is Bristol-Myers Squibb's alliance and other revenues — total revenues?: Bristol-Myers Squibb (BMY) reported alliance and other revenues — total revenues of $321M in Q1 2026.
How has Bristol-Myers Squibb's alliance and other revenues — total revenues changed year-over-year?: Bristol-Myers Squibb's alliance and other revenues — total revenues increased by 1.9% year-over-year, from $315M to $321M.
What is the long-term trend for Bristol-Myers Squibb's alliance and other revenues — total revenues?: Over 4 years (2021 to 2025), Bristol-Myers Squibb's alliance and other revenues — total revenues has grown at a 2.0% compound annual growth rate (CAGR), from $1.33B to $1.44B.
What does alliance and other revenues — total revenues mean?: Revenue earned from collaborative partnerships, profit-sharing, and royalty agreements with other companies.